ArticleNeoplasia (New York, N.Y.)2020

A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro and tumor growth in vivo.

Lijie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.